Liothyronine sodium (T3)
Brand names: Cytomel, Tertroxin
The synthetic form of the active thyroid hormone tri-iodothyronine (T3), used for severe or acute hypothyroid states such as myxoedema coma and occasionally as an adjunct in selected patients, where its rapid onset is advantageous over levothyroxine.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Liothyronine is the biologically active thyroid hormone that binds nuclear thyroid receptors to regulate metabolism, but unlike levothyroxine it acts directly without requiring peripheral conversion.
Prescribing in practice
- Its rapid, potent action makes cardiac adverse effects more likely, so start at a low dose and titrate cautiously, especially in the elderly and in those with ischaemic heart disease.
- It has a shorter half-life than levothyroxine, giving a faster onset and offset but more fluctuation in hormone levels.
- Routine substitution of liothyronine for levothyroxine in primary hypothyroidism is not recommended and should be a specialist decision.
Monitoring
Monitor thyroid function and clinical response, together with heart rate and any cardiac symptoms during dose titration.
Counselling the patient
- Take exactly as prescribed and do not change the dose yourself.
- Report palpitations, chest pain, tremor or marked anxiety.
- This is a specialist-initiated treatment and needs regular blood-test review.
Evidence & guidelines
Liothyronine has a defined role in myxoedema coma and specialist scenarios; routine combination or substitution therapy is not supported by NICE/endocrine guidance for most patients with primary hypothyroidism.
Reference: BTA position statement; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Thyroid Function Interpreter · Thyroid
- Burch-Wartofsky Point Scale for Thyrotoxicosis · Thyroid
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Burch-Wartofsky Score (Thyroid Storm) · Thyroid Crisis
- Thyroid Function Test Interpretation · Thyroid Disease
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016